Related Experiment Video
Updated: May 5, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Handgrip Strength and Dehydroepiandrosterone Sulfate in a Frailty Unit: A Retrospective Study
Daniano Caires1, Miguel Homem Costa2, João Miguel Freitas2
1Physical Medicine and Rehabilitation, Hospital Central do Funchal, Funchal, PRT.
Frailty is linked to lower handgrip strength (HGS), not dehydroepiandrosterone sulfate (DHEAS). Measuring HGS can help identify frail individuals for targeted interventions.
Area of Science:
- Gerontology
- Endocrinology
- Rehabilitation Medicine
Background:
- Frailty is a complex condition characterized by decreased physical, mental, and social activity, leading to adverse health outcomes.
- Key components of frailty include nutritional status, muscle strength, inflammation, and hormonal changes, with Dehydroepiandrosterone sulfate (DHEAS) being a hormone of interest.
- Handgrip strength (HGS) serves as a proxy for overall muscle strength, and the Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight (FRAIL) scale is a tool for frailty screening.
Purpose of the Study:
- To investigate the associations between frailty, HGS, and DHEAS in patients within a Portuguese frailty unit (FU).
- To determine if DHEAS levels correlate with frailty status or HGS measurements.
- To evaluate the relationship between HGS and frailty as assessed by the FRAIL scale.
Main Methods:
- An observational retrospective study was conducted in a FU involving patients undergoing a rehabilitation program.
- Frailty was assessed using the FRAIL scale, and DHEAS levels were measured upon admission.
- HGS was measured at admission (i-HGS) and discharge (f-HGS), with HGS variation (∆ HGS) and length of stay also considered.
Main Results:
- Frail patients (FRAIL scale score ≥ 3) exhibited significantly lower i-HGS and f-HGS compared to non-frail patients.
- DHEAS levels showed no significant association with frailty status, FRAIL scale categories, or HGS measurements.
- Lower i-HGS was independently associated with frailty, with each kilogram increase in i-HGS reducing the probability of being frail by 15%.
Conclusions:
- Frail patients demonstrate reduced HGS and longer lengths of stay in the FU.
- This study found no association between frailty and DHEAS, nor correlations between DHEAS and HGS.
- Implementing FRAIL scale screening and HGS measurement in FUs can aid in identifying frail individuals and guiding multidisciplinary interventions.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age

